Johnson & Johnson (JNJ) stock gains as FDA clears the company's Ottava surgical robot, pressuring rivals Intuitive Surgical ...
The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s JNJ OTTAVA Robotic ...
The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...
The approval marks J&J's first major step toward competing with Intuitive Surgical and Medtronic.
Johnson & Johnson (JNJ) wins FDA's De Novo authorization for the company’s soft tissue robotic system, Ottava. Read more here.
Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.
Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had granted marketing authorization for its robotic ...
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...
While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results